WWARN's latest newsletter is out

Find out more about what we've been up to in our latest newsletter. You'll find all of our news including our recent collaborative meta-analysis, commissioned by the WHO, which informed a change to its guidelines for treating uncomplicated malaria in the first trimester of pregnancy.

WWARN Newsletter December 2022

Plus, details of our 3 February webinar on 'the results of an IPD meta-analysis of tafenoquine in the context of P. Vivax radical cure' with a distinguished panel.

Other highlights include work to create a mathematical model to predict genetic resistance to antimalarial drugs in Africa, and a new study which supports the safety of a WHO recommended malaria treatment, and the first study of its kind, researchers have created bear real-time maps to support antimalarial drug resistance monitoring, using routine malaria surveillance data and individually patient linked data on molecular markers of antimalarial drug resistance.

Read the full newsletter

To stay up to date with our malaria research, sign up to our WWARN newsletter or for more information about our wider work, sign up to the IDDO newsletter.